Safety and tolerability of LBR-101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: Results of the Phase 1 program
| Image |  |
|---|---|
| Description | scientific article published on December 23, 2013 |
| Author/s | |
| Publication date | December 23, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work |
https://journals.sagepub.com/doi/pdf/10.1177/0333102413517775 |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |